A gamma-carboxyglutamate residue, or Gla residue, is a glutamate residue within a protein whose side chain carries an additional carboxyl group at its gamma carbon. It is the protein-bound form associated with gamma-carboxyglutamic acid. The amino acid residue remains part of the polypeptide backbone; the modification changes its side chain.
The distinction from the free amino acid matters experimentally. Identifying gamma-carboxyglutamic acid after breaking a protein into smaller components reveals chemical composition, while determining which residues are modified and how they are arranged requires structural or sequence evidence.[ref]
In a Gla domain, multiple Gla residues help coordinate calcium ions. A 1992 X-ray crystallography study of a prothrombin fragment resolved seven bound calcium ions in its calcium-bound structure and found substantial disorder in the corresponding calcium-free region. This illustrates how a local chemical modification can contribute to an ion-dependent folded arrangement.[ref]
Gla domain 2026-11-05
A Gla domain is a protein domain containing several gamma-carboxyglutamate residues. These are glutamate residues changed by a Vitamin K-dependent post-translational modification: an additional carboxyl group gives the modified residue extra capacity to bind calcium ions. In proteins such as prothrombin, the resulting calcium ion interactions help organize the domain's protein folding and its association with a phospholipid membrane. The residue chemistry, the folded domain and its membrane interaction are related but distinct levels of explanation.
The unusual residue was identified experimentally in 1974. J. Stenflo and colleagues found that a prothrombin fragment's electrophoretic mobility could not be explained by its ordinary amino acid composition. Nuclear magnetic resonance and mass spectrometry identified gamma-carboxyglutamic acid. The extra chemical group helped explain the fragment's calcium ion-binding behaviour.[ref]
Later, M. Soriano-Garcia and colleagues used X-ray crystallography to resolve a calcium-bound prothrombin fragment at resolution. Much of the Gla domain was disordered in the calcium-free crystal, whereas the calcium-bound structure was well defined and contained seven bound calcium ions. Their coordination by carboxylate groups and water connected residue chemistry to a three-dimensional structure. Seven is the count for that reported structure, rather than a universal definition of every Gla domain.[ref]
An appropriately positioned general base helps remove the proton from the serine residue hydroxyl, increasing its nucleophilicity. A lysine residue, such as Lys73 in the class A beta-lactamase catalytic network, is a plausible participant; its protonation state depends on its active-site environment and interactions with other residues. A glutamate residue, notably Glu166, also participates in proton transfer and activation of the water needed for deacylation. Efficient catalysis requires proton-transfer chemistry as well as positioning the attacking oxygen. The precise division of roles during acylation depends on the enzyme state, so the drawing alone cannot assign a complete mechanism to one residue.[ref]
At pH 7, a glutamate residue is normally carboxylate. Its most natural role is general-base activation of the attacking water. Draw the carboxylate oxygen lone pair toward a water H, the water O–H pair toward its oxygen, and that oxygen's lone pair toward C3 while the conjugated pi system moves toward the carbonyl oxygen:
This can be concerted, avoiding a freely diffusing hydroxide intermediate. The protonated glutamate subsequently returns its proton to the enolate system, directly or through solvent, regenerating carboxylate. A favorable arrangement is needed; ordinary carboxylate does not quantitatively deprotonate bulk water in a prior equilibrium.
The side-chain amide of glutamine is neutral. Its N–H can donate a hydrogen bond to the carbonyl oxygen and stabilize developing enolate charge, while its amide oxygen can accept a hydrogen bond to orient attacking water. Draw , with the dotted interaction from amide N–H to substrate oxygen. This assists polarization and transition state stabilization; the amide nitrogen is not an ordinary amine base because its lone pair is delocalized into its own carbonyl.
The guanidinium group of arginine is positively charged. It can stabilize developing negative charge by hydrogen bonding and electrostatic attraction, drawn . Its delocalized cation is not the preferred neutral general base at pH 7. Productive catalysis requires stronger stabilization of the reacting arrangement than of the unreactive ground-state complex.
Phenylalanine and leucine have hydrocarbon side chains and provide no conventional acid/base or hydrogen-bond donor/acceptor group here. They can position the enone, exclude unproductive solvent and select the attacked face through hydrophobic effect and steric hindrance. Those binding effects can assist catalysis but should not be drawn as an imaginary side-chain proton relay. The original schematic depicts the Glu water relay and the Gln/Arg oxyanion-stabilizing contacts.
Y91F implicates the Tyr hydroxyl, while E57Q implicates the Glu carboxylic-acid chemistry. Replacing tyrosine by phenylalanine retains an aromatic side chain but removes its hydroxyl, supporting a role for Tyr91 as a hydrogen bond donor that polarizes the steroid C3 carbonyl and stabilizes an enolate-like intermediate or transition state. Its hydroxyl could participate in a proton relay, but inactivity alone does not establish that it supplies the final proton.
Replacing a glutamate residue by glutamine approximately preserves side-chain size while replacing a titratable carboxylic acid by an amide. Loss of activity, combined with the acidic activity range, supports protonated Glu57 as a carbonyl-activating acid and possible proton donor. The two residues can cooperate to stabilize oxygen charge during reduction. The inhibitor-binding structure supports local contacts; it is not a direct picture of a testosterone transition state, and an N–H contact of the aza inhibitor need not occur in testosterone.
To distinguish these chemical roles from indirect effects, compare mutant and wild-type abundance, membrane insertion and folding, cofactor binding, and steroid binding. Measure initial rates with matched enzyme amounts and include no-enzyme and inhibitor-treated wild-type controls. If binding survives but turnover fails, the evidence for a catalytic defect is stronger. The published study combines structure, mutagenesis and modeled testosterone placement, so the proposed residue roles should be distinguished from direct observation of proton trajectories.[ref]
catalysis requires a protonated group, consistent with a general-acid contribution. Loss of its proton as pH rises would remove carbonyl activation or the proton needed to finish the conjugate reduction. A glutamate residue with a shifted active-site is a plausible candidate, but a pH cutoff alone neither identifies the residue nor measures a precise . Irreversible unfolding or changes in substrate binding must also be excluded by reversible pH jumps, protein-integrity checks and initial-rate measurements.
For the mechanistic notation below, the reduced cofactor is written NADPH, the established cofactor of human steroid 5α-reductase. The original PDF explicitly labels it NADH; its abbreviated N-substituent does not display the phosphate distinction. NADH and NADPH have the same reactive reduced nicotinamide ring, so the local hydride-transfer arrows are unchanged, although their biochemical specificity is different.[ref]
Vitamin K 2026-11-05
Vitamin K is a family of fat-soluble compounds with a shared quinone framework. It includes phylloquinone, conventionally called vitaminK1, and menaquinones, grouped as vitaminK2. The family supports an enzymatic modification required for several biologically active proteins, including proteins involved in coagulation.[ref]
An important role is supporting conversion of selected glutamate residues in proteins into gamma-carboxyglutamate residues. The protein sequence and the completed chemical modification are different kinds of information. Producing a polypeptide of the expected length does not establish that all its required modifications have occurred.[ref]
The chemistry became concrete in a 1974 prothrombin study: researchers isolated a peptide from its calcium-binding region and used nuclear magnetic resonance and mass spectrometry to identify modified glutamic acid. This linked vitamin dependence to a molecular structure that could be measured.[ref]
For a mechanistic example, consider two preparations containing the same amount of a vitamin-K-dependent protein. If one is insufficiently modified, equal protein abundance need not mean equal activity in an assay requiring the completed binding region. The example distinguishes nutrient-supported chemical maturation from simply supplying more structural protein. VitaminK is involved in several physiological systems; the name should not be reduced to a synonym for a single clotting factor.